Septic Shock Drug Development Pipeline Analysis Report 2018 - ResearchAndMarkets.com

DUBLIN--()--The "2018 Septic Shock Drug Development Pipeline Analysis Report- Companies, Drugs, Clinical Trials, Latest Developments in Septic Shock Market" report has been added to ResearchAndMarkets.com's offering.

Septic shock is a progression of sepsis condition and is life threatening in most cases. Infection which has spread to different body parts through blood is referred to as sepsis. The blood pressure in the body drops suddenly, which can result in death. Sepsis progresses to severe sepsis and then to septic shock. Symptoms include breath shortage, decline in urine volume, platelet count decrease and irregular heart beat. An estimated 1.5 million people are affected in the US per anum.

To assist researchers, investors and business development managers, the publisher has come up with a comprehensive report on Septic Shock pipeline. The report provides insights into different therapeutic candidates in preclinical, research, discovery, NDA/IND, pre registration, phase 1, phase 2, and phase 3 trials). Drugs under development directly and through combination with other drugs are also included.

Current status, developmental phase, participating companies and entities, recent developments, orphan drug/ fast track/ other designations, drug class are provided for each Septic Shock pipeline product. Mechanism of Action and the target area of the pipeline product are also provided.

In addition to complete details of each product, the report provides key trends in Septic Shock pipeline studies. The products under development are categorized according to their development phase, mechanism and company to provide detailed insights into the type of drugs being developed and the stages of development.

Companies Mentioned

  • Adrenomed AG
  • Biotest Pharmaceuticals Corporation
  • Ferring International Center S.A.
  • Hibernaid, Inc.
  • InflaRx GmbH
  • Inotrem S.A.
  • Leading BioSciences Inc.
  • Lixte Biotechnology Holdings, Inc.
  • Matisse Pharmaceuticals B.V.
  • Octapharma AG
  • Orion Oyj
  • Peptinov SAS
  • Sangui BioTech International
  • Serpin Pharma, LLC
  • XImmune AB

Key Topics Covered:

1 Table of Contents

2 Septic Shock Pipeline Analysis

3 Septic Shock- Company Wise Pipeline Analysis

4 Septic Shock R&D Pipeline Snapshots

5 Recent Developments in Septic Shock Pipeline

6 Appendix

For more information about this report visit https://www.researchandmarkets.com/research/vdgz8j/septic_shock_drug?w=4

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Drug Discovery, Infectious Diseases Drugs, Clinical Trials

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Drug Discovery, Infectious Diseases Drugs, Clinical Trials